Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
4/13/2026
Updated
4/14/26, 3:55 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership